Aegis Life launched to fight COVID-19 via DNA vaccines and therapeutics enabled by Fusogenix delivery technology
On Sept. 1, 2020, Entos Pharmaceuticals announce the launch of its San Diego-based spinout company Aegis Life, dedicated…
On Sept. 1, 2020, Entos Pharmaceuticals announce the launch of its San Diego-based spinout company Aegis Life, dedicated…
On Sept. 1, 2020, Roche announced FDA approval for the cobasï¾® HIV-1/HIV-2 Qualitative Test for use on the…
On Sept. 1, 2020, the National Institutes of Health announced that it had launched a study to track…
On Sept. 1, 2020, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published a study in…
On Sept. 1, 2020, MediciNova announced development progress on its intranasal SARS-CoV-2 vaccine for COVID-19 utilizing BC-PIV, a…
On Sept. 1, 2020, Arcadia Biosciences announced it had completed the purchase of Oregon-based Industrial Seed Innovations (ISI)…
On Sept. 1, 2020, Amyris announced that it had successfully scaled up the commercial production of Cannabigerol (CBG)…
On Sept. 1, 2020, City of Hope announced that it was investigating an innovative treatment for cancer patients…
On Sept. 1, 2020, Sanofi announced that the global Phase 3 trial investigating intravenously administered Kevzara (sarilumab) at…
On Sept. 1, 2020, HDT Bio received a notice of award from the National Institute of Allergy and…
On Sept. 1, 2020, Atossa Therapeutics announced a positive interim safety assessment from the first cohort of healthy…
In September 2020, the Centers for Disease Control and Prevention (CDC) announced the launch of the National Wastewater…
On Aug. 31, 2020, in a study published in PNAS, researchers used conservation biology and genomics to discover…
On Aug. 31, 2020, a multi-site, Phase 3 clinical trial evaluating an investigational COVID-19 vaccine known as AZD1222…
On Aug. 31, 2020, AstraZeneca announced that the COVID-19 vaccine AZD1222 expanded into U.S. Phase III clinical trial…
On Aug. 31, 2020, an international team of scientists supported by the National Institutes of Health (NIH) announced…
On Aug. 31, 2020, Vir Biotechnology and GlaxoSmithKline announced that the first patient was dosed in a phase…
On Aug. 31, 2020, Royal Philips announced that it had received notice from the U.S. Department of Health…
On Aug. 31, 2020, the Office of the Vice President for Research (OVPR) announced it had launched a…
On Aug. 31, 2020, T2 Biosystems announced that the FDA had issued an Emergency Use Authorization (EUA) for…
On Aug. 31, 2020, Novavax announced it had reached an agreement in principle with the Government of Canada…
On Aug. 31, 2020, BioCryst Pharmaceuticals announced that the National Institute of Allergy and Infectious Diseases (NIAID) had…
On Aug. 31, 2020, Todos Medical announced that it had entered into a sales agreement with a Wisconsin-based…
On Aug. 28, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health…
On Aug. 28, 2020, the U.S. Dept. of Veterans Affairs (VA) announced a new clinical trial to study…
On Aug. 28, 2020, Gilead Sciences announced the FDA expanded the Emergency Use Authorization (EUA) enabling use of…
On Aug. 28, 2020, Moderna confirmed that the Company was engaged in discussions with the Ministry of Health,…
On Aug. 28, 2020, iBio announced that it had entered into an exclusive worldwide license agreement with Planet…
On Aug. 27, 2020, the National Cancer Institute (NCI) announced a partnership with Cancer Research UK to fund…
On Aug. 27, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes…